Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
Next RNS - Price monitoring extension
I would love to be proven wrong as I hold some SNG shares. Variant agnostic solution would've attracted huge interest from big pharma and media. But nothing so far. I think the ship has sailed.
It is fair to say that if nothing materialises this week then you know that big players are not interested in SNG.
What this means is that news is not going to be out soon. If the news comes out next week, this will be classified as using insider information and both Wife and Husband will be in trouble.
Were they advertised today? GLA
I feel like buying more. Head say no Heart says yes.
OJ17 is right. Cash burn is an issue. They need to release the results soon, else they will end up offering more shares to keep the company running which in turn will result in dilution of shares.
I worked in JM for 9 years till late 2017. I saw the writing on the wall in mid 2017 with management changes. Millions of funds were diverted from Clean air to battery materials. The implementation of SAP was a train wreck. Many good directors left the business and still leaving now. I do not think Robert Macleod is retiring. He is being pushed out.
As far as eLNO is concerned, my view is that they went for delayed perfection rather than continuous improvement. By that time companies like LGChem, BASF and Umicore penetrated the market, while JM top leadership team was still bickering about how to make eLNO work.
Lets see where the SP goes when American Market opens in couple of hours. Fingers crossed for robust Covid treatment abd good ROI for fellow investors.
Yeah..massive leak in Al's Toilet Seat in new house.
I totally fail to understand how a small company like Surescreen beat AIM listed Avacta. Good on them. Although it does show Ali Cs lack of leadership. Still left with 1.2k of Avacta shares. If no news in the coming week then there is no point of holding the shares.
I pulled out of RMS with a loss. Lesson learnt. Should have questioned myself more before investing. I have kept a small pot aside but not investing until RMS gives the details of which independent bodies ran the test. I do not understand why this information has been kept confidential. It will legitimise the claim.
Does anyone know who tested the mask on P2F's behalf? I can't find any information about it.
DR777 Still invested a bit in RMS and Avacta. Atleast, Seeing Machines has got revenue coming. It is just a matter of time that some big company is going to buy it. Caterpillar would be a good bet.
Unfortunately I sold my shares at 40% loss yesterday. Awaiting for the outcome of the meeting before pressing buy. Good Luck Everyone.
I am a new shareholder of seeing machines now. I was researching its Americsn competitors. One of the competitor has just 3 people and Mcap is 2 times more than seeing machines. Either we are undervalued or overly optimistic Americans have overvalued the seeing's competitor. Good Luck Everyone. This one is going to be a long game.
I was under impression that Avacta was ahead of Mologic in terms of validation and CE marking process. What the hell happened there?
Done
If I was in Gareth Cave's shoes, I would test the mask on new strain of Corona Virus and if it is successful release RNS, whilst waiting for machine delivery.
If 4 ply was always the plan then on the advert on Pharm2farm page it should say 4 ply. The advert specifically states 5 ply design. It is a non conformance which Pharm2farm needs to overcome.